Targeting HIV-1 with CRISPR/Cas9 delivered by retargeted adenoviruses effectively suppresses viral replication
Preprint in bioRxiv (December 2023)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Preprint in bioRxiv (December 2023)
Article in Biomedicine & Pharmacotherapy (June 2023)
Article in Frontiers in Cellular and Infection Microbiology (July 2022)